Phenotypic changes in MCF-7 cells during prolonged exposure to tamoxifen

被引:24
作者
Fasco, MJ [1 ]
Amin, A
Pentecost, BT
Yang, Y
Gierthy, JF
机构
[1] New York State Dept Hlth, Dept Environm Dis Prevent, Lab Human Toxicol & Mol Epidemiol, Wadsworth Ctr, Albany, NY 12201 USA
[2] SUNY Albany, Sch Publ Hlth, Dept Environm Hlth & Toxicol, Albany, NY USA
关键词
human breast cancer; tamoxifen; estrogen receptor mRNA; alternatively spliced estrogen receptor mRNAs; estrogen receptor protein expression and estrogen receptor transcriptional regulation;
D O I
10.1016/S0303-7207(03)00256-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
MCF-7 breast tumor cells form multicellular nodules (foci) over a confluent monolayer in an estradiol (E2)-dependent, antiestrogen-sensitive reaction. A cell line cloned from MCF-7 that displays these phenotypes was probed to determine the effects of long term exposure to tamoxifen on the growth of foci, estrogen receptor alpha (ERa) status, and gene responsiveness to E2. In one of two experiments, a heterogeneous cell population emerged (TMX2) that over-expressed estrogen receptor alpha wild type mRNA (ERalpha mRNA) ( similar to 20-fold) missing exon 3 (ERDelta3 mRNA) and its corresponding protein (ERDelta3P). On a per mRNA to protein basis, ERDelta3P and wild-type ERalpha were equivalently expressed. Return of the TMX2 population to medium without tamoxifen eventually selected for a population that expressed predominately wild-type ERa, whereas TMX2 clones over expressing ERA3 mRNA and ERDelta3P retained this phenotype in tamoxifen-free media. In both experiments, expression of all ERalpha mRNAs and proteins declined to barely detectable levels during 6-12 months exposure, concomitant with a progressive increase in the ability of the cells to form foci independently of E2 or tamoxifen. Selection for these various populations suggests that tamoxifen can induce and/or support certain cellular changes that lead to altered ERalpha expression, E2-independent cell growth and resistance to antiestrogens. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:33 / 47
页数:15
相关论文
共 48 条
  • [1] Arcaro KF, 1999, J CELL BIOCHEM, V72, P94, DOI 10.1002/(SICI)1097-4644(19990101)72:1<94::AID-JCB10>3.3.CO
  • [2] 2-P
  • [3] An estrogen receptor-Lu splicing variant mediates both positive and negative effects on gene transcription
    Bollig, A
    Miksicek, RJ
    [J]. MOLECULAR ENDOCRINOLOGY, 2000, 14 (05) : 634 - 649
  • [4] Brunner N, 1997, CANCER RES, V57, P3486
  • [5] ANTIESTROGEN ICI-164,384 REDUCES CELLULAR ESTROGEN-RECEPTOR CONTENT BY INCREASING ITS TURNOVER
    DAUVOIS, S
    DANIELIAN, PS
    WHITE, R
    PARKER, MG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) : 4037 - 4041
  • [6] Presence of exon 5-deleted oestrogen receptor in human breast cancer: Functional analysis and clinical significance
    Desai, AJ
    Luqmani, YA
    Walters, JE
    Coope, RC
    Dagg, B
    Gomm, JJ
    Pace, PE
    Rees, CN
    Thirunavukkarasu, V
    Shousha, S
    Groome, NP
    Coombes, R
    Ali, S
    [J]. BRITISH JOURNAL OF CANCER, 1997, 75 (08) : 1173 - 1184
  • [7] Oestrogen receptor mutants and variants in breast cancer
    Dowsett, M
    Daffada, A
    Chan, CMW
    Johnston, SRD
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1177 - 1183
  • [8] Loss of an estrogen receptor isoform (ER alpha Delta 3) in breast cancer and the consequences of its reexpression: Interference with estrogen-stimulated properties of malignant transformation
    Erenburg, I
    Schachter, B
    Lopez, RMY
    Ossowski, L
    [J]. MOLECULAR ENDOCRINOLOGY, 1997, 11 (13) : 2004 - 2015
  • [9] Expression of an estrogen receptor alpha variant protein in cell lines and tumors (vol 162, pg 167, 2000)
    Fasco, MJ
    Keyomarsi, K
    Arcaro, KF
    Gierthy, JF
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2000, 166 (02) : 155 - 169
  • [10] Estrogen receptor mRNA splice variants produced from the distal and proximal promoter transcripts
    Fasco, MJ
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 138 (1-2) : 51 - 59